Click here to visit Company website

Arrowhead Research Corporation, a clinical stage nanomedicine company, through its subsidiaries, develops therapeutic products at the interface of biology and nanoengineering to cure disease and improve human health. It focuses on the design and development of therapeutic agents for the treatment of cancer and obesity, as well as healing wounded or diseased tissue based on nucleic acid delivery, siRNA chemistry, and tissue targeting intellectual properties.